A New Approach to the Treatment of Uncomplicated Cystitis: Results of a Randomized Placebo-Controlled Clinical Trial

Urologia Internationalis

Volumn 97, Issue 3, 2016, Pages 347-351

  Salvatorelli, Nicola ^a   García Larrosa, Alejandro ^b   Allegrini, Alessandro ^c   Pavone, Daniele ^c  

^a Local Health Unit of Pescara   (Italy)

^b HOSPITAL DEL MAR   (Spain)

^c FourPharma CRO Srl   (Italy)

Author keywords

Clinical trial; Cystitis; Recurrence; Urinary tract infections

Indexed keywords

CIPROFLOXACIN; CROSS LINKED PROTEIN; HIBISCUS SABDARIFFA EXTRACT; PLACEBO; PROPOLIS; PROTEIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; PLANT EXTRACT; POLYSACCHARIDE; UTIPRO;

ABSENCE OF SIDE EFFECTS; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; CYSTITIS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSURIA; FEMALE; FOLLOW UP; HEART RATE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MEDICAL DEVICE; MEDICAL DEVICE CAPSULE; MICTURITION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; URINE CULTURE; ACUTE DISEASE; DRUG COMBINATION; MICROCAPSULE; URINARY TRACT INFECTION;

ACUTE DISEASE; ADULT; ANTI-BACTERIAL AGENTS; CAPSULES; CIPROFLOXACIN; CYSTITIS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; PLANT EXTRACTS; POLYSACCHARIDES; PROSPECTIVE STUDIES; URINARY TRACT INFECTIONS;

EID: 84964078135     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000445326     Document Type: Article

References (20)

1. Foxman B: Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am 2014; 28: 1-13.
2. Foxman B: Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 2003; 49: 53-70.
3. Schito GC, Naber KG, Botto H, Palou J, Mazzei T, Gualco L, Marchese A: The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents 2009; 34: 407-413.
4. Andreu A: [Pathogenesis of urinary tract infections]. Enferm Infecc Microbiol Clin 2005; 23(suppl 4):15-21.
5. Bent S, Saint S: The optimal use of diagnostic testing in women with acute uncomplicated cystitis. Am J Med 2002; 113(suppl 1A):20S-28S.
6. Foxman B, Gillespie B, Koopman J, Zhang L, Palin K, Tallman P, Marsh JV, Spear S, Sobel JD, Marty MJ, Marrs CF: Risk factors for second urinary tract infection among college women. Am J Epidemiol 2000; 151: 1194-1205.
7. Ronald A: The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 2002; 113(suppl 1A):14S-19S.
8. González-Chamorro F, Palacios R, Alcover J, Campos J, Borrego F, Dámaso D: [Urinary tract infections and their prevention]. Actas Urol Esp 2012; 36: 48-53.
9. Hickling DR, Nitti VW: Management of recurrent urinary tract infections in healthy adult women. Rev Urol 2013; 15: 41-48.
10. Carlet J, Collignon P, Goldmann D, Goossens H, Gyssens IC, Harbarth S, Jarlier V, Levy SB, N'Doye B, Pittet D, Richtmann R, Seto WH, van der Meer JW, Voss A: Society's failure to protect a precious resource: antibiotics. Lancet 2011; 378: 369-371.
11. Oteo J, Pérez-Vázquez M, Campos J: Extended-spectrum [beta]-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis 2010; 23: 320-326.
12. Zowawi HM, Harris PN, Roberts MJ, Tambyah PA, Schembri MA, Pezzani MD, Williamson DA, Paterson DL: The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nat Rev Urol 2015; 12: 570-584.
13. Kahlmeter G, Åhman J, Matuschek E: Antimicrobial resistance of Escherichia coli causing uncomplicated urinary tract infections: a European update for 2014 and comparison with 2000 and 2008. Infect Dis Ther 2015; 4: 417-423.
14. Prieto L, Esteban M, Salinas J, Adot JM, Arlandis S, Peri L, Cozar JM: Consensus document of the Spanish urological association on the management of uncomplicated recurrent urinary tract infections. Actas Urol Esp 2015; 39: 339-348.
15. García-Larrosa A, Alexe O: [Utipro: a new, effective treatment against acute cystitis symptoms]. Tenerife, LXXIX Congreso Nacional de Urología, June 11-14, 2014, p 118.
16. Albert X, Huertas I, Pereiró II, Sanfélix J, Gosalbes V, Perrota C: Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev 2004; 3:CD001209.
17. Ruszczyski M, Urbaska M, Szajewska H: Gelatin tannate for treating acute gastroenteritis: a systematic review. Ann Gastroenterol 2014; 27: 121-124.
18. Ndu OO, Nworu CS, Ehiemere CO, Ndukwe NC, Ochiogu IS: Herb-drug interaction between the extract of Hibiscus sabdariffa L. and hydrochlorothiazide in experimental animals. J Med Food 2011; 14: 640-644.
19. Carlsson S, Wiklund NP, Engstrand L, Weitzberg E, Lundberg JO: Effects of pH, nitrite, and ascorbic acid on nonenzymatic nitric oxide generation and bacterial growth in urine. Nitric Oxide 2001; 5: 580-586.
20. Serban C, Sahebkar A, Ursoniu S, Andrica F, Banach M: Effect of sour tea (Hibiscus sabdariffa L.) on arterial hypertension: a systematic review and meta-analysis of randomized controlled trials. J Hypertens 2015; 33: 1119-1127.